Margarita Gekkieva

Title: Innovations by Margarita Gekkieva

Introduction

Margarita Gekkieva is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of ocular medicine, particularly in the treatment of age-related macular degeneration and other intraocular neovascular disorders. With a total of 4 patents to her name, Gekkieva's work is recognized for its potential to improve patient care and treatment outcomes.

Latest Patents

Gekkieva's latest patents include innovative methods for treating age-related macular degeneration. One of her methods focuses on reducing the treatment burden for patients by administering a therapeutically effective amount of VEGF antagonist on a dosing schedule that includes treatment intervals of 8 and/or 12 weeks. Another patent addresses ocular diseases with brolucizumab, similarly aiming to lessen the treatment burden for patients with intraocular neovascular disorders.

Career Highlights

Throughout her career, Margarita Gekkieva has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma AG. Her experience in these organizations has allowed her to develop and refine her innovative approaches to treating ocular diseases.

Collaborations

Margarita has collaborated with esteemed colleagues such as Peter Sallstig and Andreas Weichselberger. These partnerships have contributed to her success and the advancement of her research in ocular treatments.

Conclusion

Margarita Gekkieva's contributions to the field of ocular medicine through her patents and collaborations highlight her dedication to improving patient care. Her innovative methods have the potential to significantly impact the treatment of age-related macular degeneration and other ocular diseases.